JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211536200 on March 25, 2003

J. Biol. Chem., Vol. 278, Issue 23, 20490-20499, June 6, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/23/20490    most recent
M211536200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harendza, S.
Right arrow Articles by Stahl, R. A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harendza, S.
Right arrow Articles by Stahl, R. A. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Linked Common Polymorphisms in the Gelatinase A Promoter Are Associated with Diminished Transcriptional Response to Estrogen and Genetic Fitness*

Sigrid Harendza {ddagger} §, David H. Lovett ¶, Ulf Panzer {ddagger}, Zoltan Lukacs ||, Peter Kühnl ** and Rolf A. K. Stahl {ddagger}

From the Departments of {ddagger}Medicine, Division of Nephrology, ||Department of Pediatrics, and **Transfusion Medicine and Transplantation Immunology, University of Hamburg, Hamburg D-20246, Germany and the Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California 94121-1598

Gelatinase A (matrix metalloproteinase-2) plays a prominent role in multiple biologic processes. Prior studies have established critical roles for gelatinase A transcriptional regulation by defined enhancer elements. To determine possible functional single nucleotide polymorphisms within these elements, we determined the single nucleotide polymorphism distribution within 1,665 bp of the gelatinase A 5'-flanking region, using a healthy homogeneous Caucasian study group of 463 individuals. Among the polymorphisms detected, a G -> A transition at bp –1575 was located immediately 5' to a half-palindromic potential estrogen receptor binding site. In estrogen receptor-positive MCF-7 cells the –1575G allele functioned as an enhancer, whereas the –1575A allele reduced transcription activity significantly. Gel shift assays confirmed that the differences in allelic expression affected binding of the estrogen receptor-{alpha} to this region. Cotransfection experiments with an estrogen receptor-{alpha} expression vector in MDA-MB-231 cells, which do not constitutively express an estrogen receptor, revealed that estrogen receptor is absolutely required for enhancing activity. Allelic distribution analysis indicated that a previously reported C -> T transition within an Sp1 binding site at –1306 was in linkage disequilibrium with the –1575G -> A transition. Luciferase reporter studies of the linked variant –1575A –1306T allele versus the wild type –1575G –1306C allele demonstrated an additive reduction in estrogen-dependent reporter activity. The frequency of the –1575G -> A transition deviated significantly from the expected Hardy-Weinberg distribution in two independently assembled study populations consisting of healthy adult blood donors and newborns of Caucasian origin, both with a calculated 21% reduction in genetic fitness. Gelatinase A is a known estrogen-responsive gene and the demonstration of a loss of function polymorphism within an operational estrogen receptor binding site associated with a decrease in genetic fitness underscores the biologic significance of promoter polymorphism analyses.


Received for publication, November 12, 2002 , and in revised form, March 19, 2003.

* This work was supported by Deutsche Forschungsgemeinschaft Grant HA 2056/3–3 (to S. H.) and National Institutes of Health Grant DK 39776 (to D. H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Universitätsklinikum Hamburg-Eppendorf, Zentrum für Innere Medizin, Medizinische Klinik IV, Nephrologie und Osteologie, Pavillon N26, Martinistrasse 52, Hamburg D-20246, Germany.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
B. Borghese, J.-D. Chiche, D. Vernerey, C. Chenot, O. Mir, G. Bijaoui, C. Bonaiti-Pellie, and C. Chapron
Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression
Hum. Reprod., May 1, 2008; 23(5): 1207 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Higashi, S. Kyo, M. Inoue, H. Tanii, and K. Saijoh
Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-{beta} Binding Protein-1L Promoter: Effect on Latent Transforming Growth Factor-{beta} Binding Protein-1L Expression Level and Possible Prognostic Significance in Ovarian Cancer
J. Mol. Diagn., July 1, 2006; 8(3): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ye
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
Cardiovasc Res, February 15, 2006; 69(3): 636 - 645.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Zhou, C. Yu, X. Miao, Y. Wang, W. Tan, T. Sun, X. Zhang, P. Xiong, and D. Lin
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility
Carcinogenesis, June 1, 2005; 26(6): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Liu, F. Innocenti, M. H. Wu, A. A. Desai, M. E. Dolan, E. H. Cook Jr., and M. J. Ratain
A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter
Cancer Res., January 1, 2005; 65(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Conde, J. M. Vaquerizas, J. Santoyo, F. Al-Shahrour, S. Ruiz-Llorente, M. Robledo, and J. Dopazo
PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level
Nucleic Acids Res., July 1, 2004; 32(suppl_2): W242 - W248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Bourdeau, J. Deschenes, R. Metivier, Y. Nagai, D. Nguyen, N. Bretschneider, F. Gannon, J. H. White, and S. Mader
Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse
Mol. Endocrinol., June 1, 2004; 18(6): 1411 - 1427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.